Vivimed recalls hypertensive drug from US market due to impurities
According to the USFDA, the drug, Losartan Potassium Tablet, could put certain patients under a heightened risk of developing…
Author
Morepen Labs’ Q4 net profit up by 54 per cent at Rs 10.49 crore
The company declared that with the latest surge in profits, it has now officially become debt free
Medlife acquires medicine delivery startup Myra Medicines
While Myra was earlier handling about 4,000 deliveries a day in Bengaluru, its services are now ready to be scaled across 22…
Dr. Reddy’s Lab launches Testosterone Gel, 1.62% in the US
The drug company has received USFDA's approval to sell Testosterone Gel, 1.62%, which is a generic version of AndroGel
NPPA fixes retail prices for 20 formulations, revises for 2
The changes have been made under the Drugs Prices Control Order (DPCO), 2013
Amgen’s request for preliminary injunction against Cipla denied by US court
Cipla had announced a phased launch of generic cinacalcet hydrochloride tablets. However, it is a subject of ongoing litigation…
Laurus Labs revenue shoots up by 13.4 per cent in Q4 FY19
The company also reported a surge of 17.9 per cent in EBITDA for Q4 FY19, profit after taxes as Rs 432 mn
Laurus Labs has…
Manufacturing growth sees surging demand at CPhI South East Asia
The event saw over 7,000 attendees and more than 250 exhibitors over three days
Glenmark Therapeutics inks pact with Otonomy to promote Otiprio in US
The drug is indicated for treatment of inflammation of the outer ear canal
Medikabazaar appoints new EVP- Direct Sales & Revenue
He is likely to help the firm with its expansion and growth plans